1. Efficacy of intracavitary administration of cyclophosphamide, interleukin-2 and lymphokine activated killer cells against established intraperitoneal tumor;Eggermont;Acta Med Austriaca,1989
2. Intraperitoneal chemotherapy in peritoneal malignancy: impact of intensive system care on practicability;Knudli;Acta Med Austriaca,1989
3. Intraperitoneal cisplatin with systemic thiosulfate protection;Howell;Ann Intern Med,1982
4. Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with I.V. sodium thiosulfate;Canal;Acta Med Austriaca,1989
5. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer;Dedrick;Cancer Treat Rep,1978